Europe has seen a resurgence of diphtheria since 2022, with cutaneous forms predominating in vulnerable groups and declining adult vaccination rates in adults.

Health authorities urge clinicians to check vaccination status and watch for chronic or worsening wounds, especially in travellers or vulnerable patients.

Corynebacterium diphtheriae, historically recognised for its diphtheria toxin, exhibits a multifaceted interaction with its host that extends beyond toxin production. Current research underscores that ...

Learn how MSF is combating a severe diphtheria outbreak in Nigeria, treating thousands of cases and calling for urgent action ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Assistant in Clinical Bacteriology, Massachusetts General Hospital; Instructor in Bacteriology, Harvard Medical School. From the Pathological Laboratory, Massachusetts General Hospital, Dr. James ...